scholarly article | Q13442814 |
P356 | DOI | 10.1093/INTIMM/3.8.761 |
P698 | PubMed publication ID | 1911545 |
P2093 | author name string | Harada S | |
Sato S | |||
Morita M | |||
Inoko H | |||
Igarashi H | |||
Sugimoto M | |||
Maruyama I | |||
Kannagi M | |||
Kidokoro M | |||
Kuwashima G | |||
P433 | issue | 8 | |
P921 | main subject | leukemia | Q29496 |
cytotoxicity | Q246181 | ||
Human T-lymphotropic virus 1 | Q1280388 | ||
P304 | page(s) | 761-767 | |
P577 | publication date | 1991-08-01 | |
P1433 | published in | International Immunology | Q15710043 |
P1476 | title | Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells | |
P478 | volume | 3 |
Q40475835 | 6 Human T-cell leukaemia virus |
Q40116023 | A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients |
Q41397919 | A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis |
Q39704609 | APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo |
Q39574730 | ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells |
Q45362124 | Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors |
Q39875392 | Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. |
Q36967203 | Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). |
Q33245942 | Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia. |
Q64912641 | Association Between HTLV-1 Genotypes and Risk of HAM/TSP. |
Q36548660 | Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells |
Q36448106 | Atomic Coordination Reflects Peptide Immunogenicity. |
Q37945242 | Cell Surface Markers in HTLV-1 Pathogenesis |
Q37069833 | Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons |
Q36254893 | Cellular immune response to HTLV-1. |
Q33733750 | Chronic dacryosialadenitis in HTLV I associated myelopathy |
Q36633226 | Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. |
Q34156338 | Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients |
Q35120139 | Clonality of HTLV-2 in natural infection |
Q36641900 | Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions |
Q40287235 | DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells |
Q39292402 | De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice |
Q44718738 | Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers |
Q42219339 | Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice |
Q33795171 | Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade |
Q37827194 | Double control systems for human T‐cell leukemia virus type 1 by innate and acquired immunity |
Q41129466 | Dual infection of rabbits with human T cell lymphotropic virus types I and II. |
Q47598074 | Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia. |
Q45755372 | Epitope Mapping of Bovine Leukemia Virus Transactivator Protein Tax |
Q33816840 | Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax. |
Q35891748 | Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide |
Q34756170 | Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response |
Q34649734 | Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection |
Q42228781 | HBZ and its roles in HTLV-1 oncogenesis |
Q36452983 | HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy |
Q33707746 | HLA class I binding of HBZ determines outcome in HTLV-1 infection |
Q54242431 | HTLV-1 Alters T Cells for Viral Persistence and Transmission. |
Q90733114 | HTLV-1 as a Model for Virus and Host Coordinated Immunoediting |
Q37430368 | HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling |
Q38169485 | HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection |
Q36112549 | HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals |
Q34316662 | HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP. |
Q45096240 | HTLV-1-associated myelopathy/tropical spastic paraparesis |
Q34270849 | HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells |
Q54699187 | HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy. |
Q39149923 | HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals |
Q37014310 | High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response |
Q36361794 | High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease |
Q47548079 | How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response? |
Q34683956 | Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction? |
Q91967437 | Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection |
Q40046615 | Human T-cell leukaemia virus type 1: parasitism and pathogenesis |
Q37142785 | Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination |
Q24805664 | Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) |
Q99711033 | Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma |
Q100311468 | Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent |
Q35611766 | Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control |
Q45443442 | Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse |
Q38906679 | IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population. |
Q40041190 | IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. |
Q90639358 | IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia |
Q33908704 | Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation |
Q33651831 | Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). |
Q36944303 | Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia |
Q38056376 | Immunological homeostasis of the eye |
Q36422111 | Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives |
Q34203309 | Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production |
Q92787350 | Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL |
Q36944299 | Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia |
Q41403895 | In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors |
Q40267146 | In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes |
Q39200260 | In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP). |
Q39422572 | Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients |
Q35909704 | Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax. |
Q35892641 | Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax |
Q38264568 | Integration site and clonal expansion in human chronic retroviral infection and gene therapy. |
Q39815291 | Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. |
Q55240180 | Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells. |
Q41723007 | Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma? |
Q35611774 | Leukemogenesis of adult T-cell leukemia |
Q45710708 | Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma |
Q26801294 | Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence |
Q37266106 | Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1 |
Q34332433 | Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression |
Q38128799 | Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis |
Q38032236 | New insight into the oncogenic mechanism of the retroviral oncoprotein Tax |
Q35836191 | Novel CD8(+) cytotoxic T cell epitopes in bovine leukemia virus with cattle. |
Q92381563 | Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle |
Q47578584 | Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development |
Q33783833 | Oral Administration of Human T-Cell Leukemia Virus Type 1 Induces Immune Unresponsiveness with Persistent Infection in Adult Rats |
Q39182964 | Potential Contribution of a Novel Tax Epitope–Specific CD4+ T Cells to Graft-versus-Tax Effect in Adult T Cell Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation |
Q39124766 | Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy |
Q33811681 | Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine |
Q35067468 | Quantum chemical calculations predict biological function: the case of T cell receptor interaction with a peptide/MHC class I. |
Q35023802 | Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells |
Q33956264 | Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity. |
Q38262353 | Regulation of HTLV-1 tax stability, cellular trafficking and NF-κB activation by the ubiquitin-proteasome pathway |
Q37093004 | Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model |
Q26774352 | Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases |
Q47550200 | Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells |
Q37583516 | Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding |
Q39138338 | Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon |
Q39119691 | Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells |
Q39147176 | Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. |
Q53160634 | Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma |
Q37317982 | The HBZ gene, a key player in HTLV-1 pathogenesis |
Q42267172 | The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB. |
Q39377294 | The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) |
Q26768630 | The Role of HBZ in HTLV-1-Induced Oncogenesis |
Q39218366 | The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin‐10 in human T‐cell lymphotropic virus type‐1‐infected T cells |
Q36150424 | The coordination of unprotonated peptide tertiary structure as a metric of pMHC-TCR functional avidity. |
Q33971004 | The immune response to HTLV-I. |
Q39119670 | The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases |
Q26744327 | Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus |
Q35214398 | Tumor-associated antigens: from discovery to immunity |
Q42488942 | Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues |
Q38100771 | Virological and immunological mechanisms in the pathogenesis of human T‐cell leukemia virus type 1 |
Q39879902 | cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence |
Search more.